Our studies showed that a miRNA designed to target HER2 mRNA and delivered to HER2-positive cells via exosomes blocked the replenishment of HER2 and ultimately showed anti-tumor effects on these cells by activation of apoptosis pathway. This evidence concerns the gene ERBB2 and neoplasm.